# Vitalant – FDA Inspection, Nov 8, 2016

Source: https://www.keypedia.com/records/fda_inspections/vitalant/ac339770-3878-4491-88d0-23347b58d599
Source feed: FDA_Inspections

> FDA inspection 1014839 of Vitalant, November 08, 2016. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014839
- Company Name: Vitalant
- Inspection Date: 2016-11-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1320244 - 2026-05-29
- FDA Inspection 1201540 - 2023-03-02
- FDA Inspection 1074771 - 2018-12-04
- FDA Inspection 907184 - 2014-12-16
- FDA Inspection 807329 - 2012-11-14

## Related Officers

- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/jayne-e-holcomb/c4ebf3a0-6100-456f-ba3e-a19d33ad4a99)

Company: https://www.keypedia.com/companies/vitalant/d7a51565-192a-4bc9-84e3-5ff94bb98f7c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d